Clinica de la Costa S.A.S. ( Site 0400)

Barranquilla, Atlántico 080020

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Heterozygous Familial Hypercholesterolemia (HeFH)

Studies at this site

• A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029) — Recruiting now
• Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) — Running, not enrolling